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Psychological response and needs in a 
disaster
• Provide for basic needs
• Protect from further harm
• Reduce agitation and 
arousal
• Support those most in 
distress
• Keep families together 
and provide social support
• Provide information, 
foster communication and 
education
• Orient to available 
services
• Use effective risk 
communication 
techniques
”It’s a marathon, not a sprint.” –US Agency for International Development office, Sri Lanka, January 2005
Risk factors for 
post-disaster 
psychopathology
• Dose of trauma, level of exposure to the event
• Prior exposure to trauma such as disaster
• Prior psychiatric history
• Problems of living prior to disaster/low SES
• Lack of perceived or actual social supports after 
the trauma
• Presence of secondary stresses
• Female
• Middle age
• Ethnic minority
COVID-19 
pandemic 
effects on SUD 
treatment
• Barriers to inpatient treatment 
• Barriers to regular face-to-face maintenance visits
• Increased stress, risk for setbacks
• Economic stressors, risk of diversion
• Support/recovery groups not meeting (some moving 
online)
• Increased risk of more severe forms of COVID-19
• COVID-19 maps onto SUD vulnerabilities
• Lockdown policies
• Re-purposing of beds, pharmacies, lab, 
hospitals/clinics to COVID-19
COVID-19 
guidance for 
OUD 
treatment 
programs and 
clinicians
• Triggers and relapse 
• Plan for additional stress, make a maintenance 
plan
• Counseling and meetings – look for alternatives to 
face-to-face meetings
• Online options include AA Intergroup (http://aa-
intergroup.org/) and Smart Recovery 
(www.smartrecovery.org, click "online 
community").
• Do not make medication prescription contingent 
upon meeting/therapy attendance
• Drug monitoring
• Identify patient-centered strategies, creative 
solutions to monitoring
COVID-19 
guidance for 
OUD 
treatment 
programs and 
clinicians
• Access to medications/interim medications
• Continuous access even if quarantined/isolated
• Avoid universal monitoring
• Telehealth options
• Medication delivery option
• Consider take home doses as appropriate (despite 
diversion risks), especially in cases of COVID 
infection/exposure
• Shifting to longer acting medications if possible to 
reduce visits
• Backup system (3-4 providers deep) for your patients if 
you become unavailable, remote medical access
• Smoking and vaping
• Travel
• Age and Other Medical Conditions
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Trends in 
other parts of 
the world
• “Falling through the cracks in quarantine” 
• (https://medicine.yale.edu/news/yale-medicine-
magazine/falling-through-the-cracks-in-
quarantine/)
• Medication shortages
• Dispensing interruptions
• Interruptions in safe injectables
• “Non-essential” visits/visitors, triaging of beds, clinic 
space
• Usual sources of drugs not available, what will be 
substituted
• Prolonged effects of this pandemic for SUD 
treatment community
Resources
• Fliers shared on ECHO site
• https://www.samhsa.gov/coronavirus
https://www.bridgetotreatment.org/covid-19
• https://crackdownpod.com/podcast/episode-14-
emergency-measures/
• https://www.addictionpolicy.org/connections-app
• https://www.addictionpolicy.org/post/free-
smartphone-app-offering-telehealth-support-for-
those-struggling-with-addiction-during-covid-19
• https://www.addictionpolicy.org
• https://medicine.yale.edu/news/yale-medicine-
magazine/falling-through-the-cracks-in-quarantine/
